INmune Bio

$14.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.85 (+26.46%) Today
+$0.38 (+2.79%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell INmune Bio and other stocks, options, and ETFs commission-free!

About INMB

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE.

CEO
Raymond J. Tesi
Employees
5
Headquarters
La Jolla, California
Founded
2015
Market Cap
188.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
144.82K
High Today
$14.00
Low Today
$10.52
Open Price
$10.67
Volume
617.14K
52 Week High
$29.99
52 Week Low
$3.92

INMB Earnings

-$0.36
-$0.24
-$0.12
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

SCS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure